Search clinical trials for: Clinical Trial, Phase1

Total 58751 results

Green Cross Corporation
Quintiles, Inc.

Completed

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Healthy Male

United States
AstraZeneca

Active, not recruiting

MEDI5752 in Japanese Patients With Advanced Solid Tumors.

Advanced Solid Tumors

Japan
Pfizer

Completed

Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects

Healthy

United States
Pfizer

Completed

First In Human Study Of Increasing Oral Doses Of PF-04634817

Healthy

United States
Celgene

Terminated

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants

Healthy Volunteers

Belgium
Celgene

Completed

A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

Japan
Viela Bio
CTI Clinical Trial and Consulting Services

Terminated

A Phase1 Study of VIB9600

Safety Issues

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)

Leukemia, Myeloid, Acute

China
Astellas Pharma Inc
Agensys, Inc.

Terminated

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Carcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian Cancer

United States
Novartis Pharmaceuticals

Completed

Phase I Dose Escalating Study of TKI258

Advanced Solid Tumors

Japan
SuZhou Stainwei Biotech Inc.

Unknown

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Solid Tumors

China
Stalicla SA
National Institute on Drug Abuse (NIDA)

Recruiting

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Cocaine Use Disorder

United States
SPARK Biopharma

Completed

SB17170 Phase1 Trial in Healthy Volunteer

Pharmacokinetics | Pharmacodynamics | Safety Issues | Tolerability

Korea, Republic of
LG Life Sciences

Completed

Study of LC23-1306 in Healthy Male Subjects

Acute Coronary Syndrome

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin; MICALIS Institute

Recruiting

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. (ASCENSION)

Crohn's Disease

France
GlaxoSmithKline

Completed

Japanese phase1 Study of Belimumab (IV vs SC)

Systemic Lupus Erythematosus

Japan
Pfizer

Completed

Phase1, Single Dose, Crossover Study to Determine Bioequivalence

Healthy

Singapore
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Development of a Behavioral Observer for Type 1 Diabetes Mellitus (Phase1)

Diabetes Mellitus, Type 1

United States
Columbia University

Suspended

taVNS for Persistent Symptoms From Lyme Disease

Post-Treatment Lyme Disease

United States
Bastyr University
National Institutes of Health (NIH); National Center for Complementary and...

Terminated

Complementary and Alternative Medicine Sauna Detoxification Study: Phase I

Hyperthermia

United States
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Type2 Diabetes Mellitus

Korea, Republic of
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Muscle Spasticity

Korea, Republic of
BioSight Ltd.

Completed

Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (BSTPHASE1-01)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

Israel
SolAeroMed Inc.

Completed

Phase1, Placebo-Controlled, Randomized, Double-blind, Single-ascending Dose Study in Healthy Subjects.

Asthma
Innate Pharma

Recruiting

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States, Australia
Centre Hospitalier Universitaire, Amiens
Merck Serono International SA

Completed

May Metformin be Used in Renal Failure?

Renal Disorder Associated With Type II Diabetes Mellitus

France
Rhode Island Hospital
University of Puerto Rico

Completed

A Sleep Hygiene Intervention to Improve Sleep Quality in Urban, Latino Middle School Children - Phase 1

Sleep | Sleep Hygiene, Inadequate

United States, Puerto Rico
University of Zurich
Charite University, Berlin, Germany; First Teaching Hospital of Tianjin University...

Completed

Mechanisms of Acupuncture Analgesia on Experimental Dental Pain - A Psychophysical Study (Phase1) (MAC-DENT1)

Experimental Dental Pain

Switzerland
Prestige Biopharma Limited

Recruiting

First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer

Pancreatic Cancer

Spain, United States
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

GERD

Korea, Republic of
Michelle Melisko

Terminated

Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+

Solid Tumor

United States
GlaxoSmithKline

Completed

Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males

Influenza, Human

Japan
SK Chemicals Co., Ltd.
Korea University Anam Hospital

Completed

Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III

Healthy

Korea, Republic of
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Completed

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)

Pancreatic Cancer

Japan
Radboud University Medical Center
Adrenomed AG

Completed

Adrecizumab Phase 1 Trial

Healthy Volunteers

Netherlands
InnoPharmax Inc.

Completed

Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas

Advanced Solid Malignancies | Malignant Lymphomas

Taiwan
Fukushima Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo

Unknown

HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

Pancreatic Cancer

Japan
Rigshospitalet, Denmark

Not yet recruiting

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Hematologic Cancer | CRS - Cytokine Release Syndrome
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam

Cannabis Use Disorder

United States
Chugai Pharmaceutical

Completed

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Hyperphosphatemia

United States
Heartland Health Research Alliance
Indiana University School of Medicine

Recruiting

The Heartland Study

Pregnancy Complications | Pregnancy Related | Miscarriage | Gestational Age and Weight Conditions | Spontaneous Abortion | Birth Defect | Exposure to Herbicides

United States
University of California, Los Angeles
University of California, San Diego

Enrolling by invitation

Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use (UCimFREE)

Opioid-use Disorder

United States
Janssen Research & Development, LLC

Terminated

A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

France, United Kingdom, Spain, Belgium, Netherlands, Germany, Denmark
AstraZeneca

Completed

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Advanced Solid Malignancies | Malignant Lymphoma

United Kingdom, Japan
Neurodegenerative Disease Research Inc

Recruiting

Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults

Tolerance | Safety Issues

United States
Weill Medical College of Cornell University
National Institute of Nursing Research (NINR)

Completed

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 1 (Oncolo-GIST)

Critical Illness | Communication | Oncology

United States
Lahey Clinic
National Evaluation System for health Technology Coordinating Center (NESTcc) and other collaborators

Completed

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease

Peripheral Arterial Disease

United States
Universidad Nacional Autonoma de Mexico
Istituto Auxologico Italiano; Medica Sur Clinic & Foundation

Unknown

Virtual Environments For Supporting Obesity Treatment (AVATOB)

Obesity | Morbid Obesity

Mexico
Sun Yat-sen University

Recruiting

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Lymphoma, Lymphoblastic

China
Purdue Pharma LP

Completed

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Chronic Nonmalignant and Nonneuropathic Pain

United States

Search clinical trials for: Clinical Trial, Phase1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations